Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity-Reference-Cited by-同舟云学术

Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity

Published:2019-04-23 Issue:24 Volume:131 Page:8193-8198
ISSN:0044-8249
Container-title:Angewandte Chemie
language:en
Short-container-title:Angew. Chem.

Author:

Babak Maria V.¹²^ORCID,Zhi Yang¹,Czarny Bertrand³,Toh Tan Boon⁴^ORCID,Hooi Lissa⁴,Chow Edward Kai‐Hua⁴⁵^ORCID,Ang Wee Han²⁶^ORCID,Gibson Dan⁷^ORCID,Pastorin Giorgia¹⁶⁸^ORCID

Affiliation:

1. Department of Pharmacy National University of Singapore 3 Science Drive 2 117543 Singapore Singapore

2. Department of Chemistry National University of Singapore 3 Science Drive 2 117543 Singapore Singapore

3. School of Materials, Science and Engineering, and Lee Kong Chian School of Medicine (LKCmedicine) Nanyang Technological University 50 Nanyang Avenue 639798 Singapore Singapore

4. Cancer Science Institute of Singapore National University of Singapore 14 Medical Drive 117599 Singapore Singapore

5. Department of Pharmacology Yong Loo Lin School of Medicine National University of Singapore Singapore

6. NUS Graduate School for Integrative Sciences and Engineering Singapore

7. Institute for Drug Research School of Pharmacy The Hebrew University Jerusalem 91120 Israel

8. NUS Nanoscience & Nanotechnology Initiative (NUSNNI) National University of Singapore 2 Engineering Drive 3 117411 Singapore Singapore

Funder

National University of Singapore

Israel Science Foundation

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ange.201903112

Reference39 articles.

1. Current Status of Platinum-Based Antitumor Drugs

3. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate

4. In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pt(iv) anticancer prodrugs bearing an oxaliplatin scaffold: what do we know about their bioactivity?;Inorganic Chemistry Frontiers;2024

2. Biotinylated Pt(iv) prodrugs with elevated lipophilicity and cytotoxicity;Dalton Transactions;2023

3. Pt(IV) Prodrug as a Potential Antitumor Agent with APE1 Inhibitory Activity;Journal of Medicinal Chemistry;2022-11-16

4. Electrochemical Detection of a Novel Pt(IV) Prodrug with the Metronidazole Axial Ligand in the Hypoxic Area;Inorganic Chemistry;2022-09-01

5. Arene‐Ruthenium(II)/Osmium(II) Complexes Potentiate the Anticancer Efficacy of Metformin via Glucose Metabolism Reprogramming;Angewandte Chemie International Edition;2022-08-11